Kirill Berezhnoi1,2, Leonid Kokov3, Alexandr Vanyukov1. 1. Department of Interventional Cardiology, City Clinical Hospital No. 52, Moscow, Russian Federation. 2. Department of Radiology, I.M Sechenov First Moscow State Medical University, Moscow, Russian Federation. 3. Department of Interventional Cardiology, N.V. Sklifosovsky Institute, Moscow, Russian Federation.
Abstract
BACKGROUND: The effects of complete revascularization (CR) on long-term treatment outcomes in patients over 80 years of age with acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD) have not been sufficiently investigated. METHODS: In this study, we analyzed data obtained in 305 patients over 80 years of age with MVD who were admitted in the period from January 2014 to August 2017 for ACS. The patients were divided into two groups. CR was performed in 131 patients, and 174 subjects had an intervention on the symptomatic artery only [incomplete revascularization (ICR)]. The primary endpoint was one-year occurrence of the major adverse cardiac events (MACE) including death, non-fatal myocardial infarction, stroke. We also recorded cases of repeat coronary artery intervention, major bleeding events, contrast-induced nephropathy and stent thrombosis that occurred within a period of 1 year. RESULTS: The MACE rate in patients undergoing CR was significantly lower during the 12-month observation period. No statistically significant differences were observed in the rates of repeat coronary artery intervention, bleeding events, contrast-induced nephropathy, and stent thrombosis. CONCLUSIONS: CR performed in patients over 80 years of age with ACS due to MVD decreases the incidence of MACE without increasing the risk of periprocedural complications.
BACKGROUND: The effects of complete revascularization (CR) on long-term treatment outcomes in patients over 80 years of age with acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD) have not been sufficiently investigated. METHODS: In this study, we analyzed data obtained in 305 patients over 80 years of age with MVD who were admitted in the period from January 2014 to August 2017 for ACS. The patients were divided into two groups. CR was performed in 131 patients, and 174 subjects had an intervention on the symptomatic artery only [incomplete revascularization (ICR)]. The primary endpoint was one-year occurrence of the major adverse cardiac events (MACE) including death, non-fatal myocardial infarction, stroke. We also recorded cases of repeat coronary artery intervention, major bleeding events, contrast-induced nephropathy and stent thrombosis that occurred within a period of 1 year. RESULTS: The MACE rate in patients undergoing CR was significantly lower during the 12-month observation period. No statistically significant differences were observed in the rates of repeat coronary artery intervention, bleeding events, contrast-induced nephropathy, and stent thrombosis. CONCLUSIONS: CR performed in patients over 80 years of age with ACS due to MVD decreases the incidence of MACE without increasing the risk of periprocedural complications.
Authors: Duk-Woo Park; Robert M Clare; Phillip J Schulte; Karen S Pieper; Linda K Shaw; Robert M Califf; E Magnus Ohman; Frans Van de Werf; Sameer Hirji; Robert A Harrington; Paul W Armstrong; Christopher B Granger; Myung-Ho Jeong; Manesh R Patel Journal: JAMA Date: 2014-11-19 Impact factor: 56.272
Authors: Mustafa Toma; Christopher E Buller; Cynthia M Westerhout; Yuling Fu; William W O'Neill; David R Holmes; Christian W Hamm; Christopher B Granger; Paul W Armstrong Journal: Eur Heart J Date: 2010-06-08 Impact factor: 29.983
Authors: Timm Bauer; Uwe Zeymer; Matthias Hochadel; Helge Möllmann; Franz Weidinger; Ralf Zahn; Holger M Nef; Christian W Hamm; Jean Marco; Anselm K Gitt Journal: Int J Cardiol Date: 2011-12-20 Impact factor: 4.164
Authors: Christian W Hamm; Jean-Pierre Bassand; Stefan Agewall; Jeroen Bax; Eric Boersma; Hector Bueno; Pio Caso; Dariusz Dudek; Stephan Gielen; Kurt Huber; Magnus Ohman; Mark C Petrie; Frank Sonntag; Miguel Sousa Uva; Robert F Storey; William Wijns; Doron Zahger Journal: Eur Heart J Date: 2011-08-26 Impact factor: 29.983
Authors: Stephan Windecker; Philippe Kolh; Fernando Alfonso; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart J Head; Peter Jüni; A Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Josef Neumann; Dimitrios J Richter; Patrick Schauerte; Miguel Sousa Uva; Giulio G Stefanini; David Paul Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski Journal: Eur Heart J Date: 2014-08-29 Impact factor: 29.983
Authors: Adam de Belder; Jose M de la Torre Hernandez; Ramon Lopez-Palop; Peter O'Kane; Felipe Hernandez Hernandez; Julian Strange; Federico Gimeno; James Cotton; Jose F Diaz Fernandez; Pilar Carrillo Saez; Martyn Thomas; Eduardo Pinar; Nick Curzen; Jose A Baz; Nina Cooter; Inigo Lozano; Nicola Skipper; Derek Robinson; David Hildick-Smith Journal: J Am Coll Cardiol Date: 2013-11-21 Impact factor: 24.094
Authors: Edward L Hannan; Chuntao Wu; Gary Walford; David R Holmes; Robert H Jones; Samin Sharma; Spencer B King Journal: JACC Cardiovasc Interv Date: 2009-01 Impact factor: 11.195
Authors: David S Wald; Joan K Morris; Nicholas J Wald; Alexander J Chase; Richard J Edwards; Liam O Hughes; Colin Berry; Keith G Oldroyd Journal: N Engl J Med Date: 2013-09-01 Impact factor: 91.245
Authors: Matthias Eberhard; Tin Nadarevic; Andrej Cousin; Jochen von Spiczak; Ricarda Hinzpeter; Andre Euler; Fabian Morsbach; Robert Manka; Dagmar I Keller; Hatem Alkadhi Journal: Cardiovasc Diagn Ther Date: 2020-08
Authors: Ada Del Mar Carmona-Segovia; María Victoria Doncel-Abad; Víctor M Becerra-Muñoz; Jorge Rodríguez-Capitán; Fernando Sabatel-Pérez; María Flores-López; María José Sánchez-Quintero; Dina Medina-Vera; Ana Isabel Molina-Ramos; Rajaa El Bekay; José Miguel Morales-Asencio; María Angullo-Gómez; Luis García-Rodríguez; Lucía Palma-Martí; Francisco Javier Pavón-Morón; Manuel F Jiménez-Navarro Journal: BMJ Open Date: 2022-02-28 Impact factor: 2.692